Electroconvulsive therapy (ECT) is not FDA-approved for post-traumatic stress disorder (PTSD), and it doesn’t have an established clinical indication for PTSD in the way it does for severe depression, mania, catatonia, or treatment-resistant psychotic disorders. That said, over the past several years there has been mounting evidence suggesting that ECT may be helpful for some patients with particularly severe PTSD, especially when comorbid with major depression.

There have been a few recent meta-analyses showing a beneficial signal. One open question is whether this effect is simply due to ECT treating comorbid depression, with downstream improvements in PTSD symptom scales, or whether ECT is directly affecting core PTSD pathology itself. That question isn’t settled. But many clinicians, myself included, suspect that there may be a more direct effect.

Part of that suspicion comes from clinical experience. I’ve treated patients where the primary indication for ECT was major depression, but who also had severe, comorbid PTSD. In a few cases, patients told me something interesting: ECT didn’t help their depression very much, but it substantially improved their PTSD symptoms. They felt less anxious, less hypervigilant, and less easily triggered. For them, the main reason to continue ECT wasn’t mood improvement, it was relief from PTSD symptoms.

At first, these were unusual isolated cases. But as I became more aware of the broader case literature, it started to feel less anomalous and more like a real signal worth taking seriously.

So how could ECT plausibly help PTSD?

At a very basic level, ECT is a highly non-specific brain intervention. You are passing an electrical current through large swaths of brain tissue and inducing a generalized tonic-clonic seizure. We know ECT affects synaptic plasticity and appears to stimulate neurogenesis in certain regions, particularly the hippocampus. Given how non-specific its effects are, it wouldn’t be surprising if ECT also modulates circuits involved in PTSD, including amygdala-centered threat and fear networks.

This kind of non-specificity is actually the norm in psychiatry. Many of our treatments affect multiple circuits at once, which is why the same medications and interventions often work across diagnostic categories.

One core feature of PTSD is overlearning or overgeneralization. A traumatic event becomes decoupled from its original context and generalized far beyond where it should apply. For example, a combat veteran who experienced an IED explosion may later experience intense fear responses in entirely different settings, back home, years later, triggered by something like fireworks. The brain has failed to properly contextualize the trauma as something that occurred in a specific time and place.

That’s essentially a failure of contextual learning. Because the hippocampus plays a key role in contextualization, one speculative idea is that ECT’s effects on hippocampal plasticity might help loosen this pathological overgeneralization. This is admittedly a hand-wavy explanation, but it’s at least biologically plausible.

Another mechanism that feels more immediately compelling to me involves the autonomic nervous system.

During a typical ECT treatment, there is a characteristic triphasic autonomic response. First, there is parasympathetic activation, which can cause bradycardia or even brief asystole. That is followed by a sympathetic surge with transient but often marked hypertension and tachycardia. Finally, there is a return of parasympathetic activity that brings the system back toward baseline.

Over the course of an ECT series, the brain adapts. Seizure threshold increases, and autonomic recovery tends to become faster. Clinically, this looks like the sympathetic surge shutting off more quickly and the parasympathetic system reasserting control sooner.

PTSD is strongly associated with autonomic hyperactivation, particularly excessive sympathetic tone. If ECT enhances the nervous system’s ability to down-regulate sympathetic activation and restore parasympathetic balance, that could directly target a core physiological component of PTSD. This idea also aligns conceptually with other investigational PTSD treatments that target autonomic regulation, such as stellate ganglion block.

There’s also a more indirect but important possibility: ECT may improve overall cognitive flexibility. If that’s the case, it could make patients more able to engage in and benefit from psychotherapy, which remains the most effective treatment modality for PTSD. In that sense, ECT wouldn’t be replacing psychotherapy, but potentially enabling it.

So while ECT is not a first-line or standard treatment for PTSD, there is growing evidence, and plausible biology, suggesting it can be useful in severe cases, particularly when comorbid depression is present. At minimum, it’s something worth keeping in mind and discussing thoughtfully with patients when conventional approaches haven’t been enough.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit brandonbrownmd.substack.com